Trial intelligence / Profile preview

Minocycline and Tretinoin for Acne Relapse

NCT00240513Phase 4Terminated

Sponsor
DermResearch
Start
Aug 2004
Primary completion
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of tretinoin in acne vulgaris (2 arms), sponsored by DermResearch. Primary endpoint: Long-term efficacy at 4 years. Started Aug 2004; status: terminated.

02

Drugs

tretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT00240513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00240513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call